NEW YORK, May 8, 2017 /PRNewswire/ --
Reports Coverage has been initiated by Stock-Callers.com on these four equities: Genpact Ltd (NYSE: G), Interpace Diagnostics Group Inc. (NASDAQ: IDXG), TransUnion (NYSE: TRU), and Vantiv Inc. (NYSE: VNTV). These companies belong to the highly fragmented Business Services category. The production in this space is divided among many different companies, as no single firm has a large enough share of the market to be able to influence the industry's direction or price levels. Learn more about these stocks by downloading their comprehensive and free reports at: http://stock-callers.com/registration
Hamilton, Bermuda-based Genpact Ltd's shares finished Friday's session 0.16% lower at $25.03. A total volume of 1.02 million shares was traded. The stock has gained 6.28% in the last month, 0.29% over the previous three months, and 3.09% on an YTD basis. The Company's shares are trading above their 50-day and 200-day moving averages by 3.40% and 3.80%, respectively. Moreover, shares of Genpact, which provides business process outsourcing and information technology management services worldwide, have a Relative Strength Index (RSI) of 65.85.
On May 03rd, 2017, Genpact has acquired BrightClaim and their associated company National Vendor, both leading providers of integrated claims solutions to the US Property and Casualty Insurance market. The acquisition marries domain expertise with advanced technologies to fundamentally change how insurers manage the claims process, allowing carriers to create a seamless, claims experience for their customers. G complete research report is just a click away and free at: http://stock-callers.com/registration/?symbol=G
Shares in Parsippany, New Jersey headquartered Interpace Diagnostics Group Inc. ended the day 1.24% lower at $2.38 with a total trading volume of 362,459 shares. The stock has advanced 7.21% in the last month. The Company's shares are trading 3.92% below their 50-day moving average. Moreover, shares of Interpace Diagnostics, which develops and commercializes molecular diagnostic tests to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers, have an RSI of 47.99.
On April 18th, 2017, Interpace Diagnostics Group announced that UnitedHealthcare, the largest health plan in the US, has agreed to cover Interpace's ThyraMIR® test used in assessing indeterminate thyroid nodule fine needle aspirate biopsies. The coverage is now in effect and is subject to members' specific benefit plan design. The complimentary report on IDXG can be downloaded at: http://stock-callers.com/registration/?symbol=IDXG
Chicago, Illinois headquartered TransUnion's stock rose 1.73%, closing the session at $41.08. A total volume of 1.94 million shares was traded, which was above their three months average volume of 1.26 million shares. The Company's shares have gained 7.82% in the last one month, 25.70% in the previous three months, and 32.82% on an YTD basis. The stock is trading 7.18% above its 50-day moving average and 21.10% above its 200-day moving average. Additionally, shares of TransUnion, which provides risk and information solutions, have an RSI of 67.71.
On April 21st, 2017, TransUnion announced the expansion of its Patient Access solution suite with the launch of its Prior Authorization solution and the enhancement of its Insurance Eligibility offering. The Prior Authorization solution helps ensure that providers will be reimbursed for the patient-care services the Company provides. The Insurance Eligibility solution has been enhanced to help streamline front-end workflows by integrating directly into hospital electronic health records. Sign up for your complimentary research report on TRU at: http://stock-callers.com/registration/?symbol=TRU
On Friday, shares in Cincinnati, Ohio headquartered Vantiv Inc. finished the session 0.69% higher at $63.85. A total volume of 1.28 million shares was traded, which was above their three months average volume of 1.09 million shares. The stock has gained 2.59% in the last month, 0.36% over the previous three months, and 7.09% on an YTD basis. The Company's shares are trading above their 200-day moving average by 7.32%. Furthermore, shares of Vantiv, which through its subsidiary, Vantiv Holding, LLC, provides electronic payment processing services to merchants and financial institutions in the US, have an RSI of 51.39.
On April 25th, 2017, Vantiv announced its agreement to acquire Paymetric, a portfolio company of Francisco Partners. Headquartered in Atlanta, GA, Paymetric automates B2B payment workflows within enterprise systems, including SAP, Oracle, Hybris, Salesforce, and more. Paymetric also tokenizes payments data within these systems in order to enable secure storage of customer information and history. Get free access to your research report on VNTV at: http://stock-callers.com/registration/?symbol=VNTV
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://stock-callers.com/legal-disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA